H. B. Muss

Competing Causes of Death From a Randomized Trial of Extended Adjuvant Endocrine Therapy for Breast Cancer

J-AW Chapman, D. Meng, L. E. Shepherd et al. · JNCI Journal of the National Cancer Institute · 2008 · 182 citations · Full text

Medicine, Oncology, Cancer Epidemiology +14

Differences Between Black and White Women With Breast Cancer in Time From Symptom Recognition to Medical Consultation

Ralph J. Coates, Diana D. Bransfield, Margaret Wesley et al. · JNCI Journal of the National Cancer Institute · 1992 · 117 citations

Medicine, Oncology, Cancer Epidemiology +16

Updated analysis of the NCIC CTG MA.17 randomized placebo (P) controlled trial of letrozole (L) after five years of tamoxifen in postmenopausal women with early stage breast cancer

Paul E. Goss, J. N. Ingle, Silvana Martino et al. · Journal of Clinical Oncology · 2004 · 82 citations

Pharmacy, Oncology, Pharmacotherapy +17

Whole abdominal radiotherapy versus combination doxorubicin-cisplatin chemotherapy in advanced endometrial carcinoma: A randomized phase III trial of the Gynecologic Oncology Group

Marcus E. Randall, Giacoma Maria Floriana Brunetto, H. B. Muss et al. · Journal of Clinical Oncology · 2003 · 66 citations

Medicine, Gynecology, Oncology +11

Low-dose ara-C therapy for acute myelogenous leukemia in elderly patients.

Bayard L. Powell, Robert L. Capizzi, H. B. Muss et al. · PubMed · 1989 · 44 citations

Medicine, Hematology, Oncology +8